ストックスクリーナーアプリを入手
0.2105
3.17%
-0.0069
アフターアワーズ：
.21
-0.0005
-0.24%
前日終値:
$0.2174
開ける：
$0.2193
24時間の取引高:
1.76M
Relative Volume:
0.34
時価総額：
$4.55M
収益：
$149.50K
当期純損益:
$-6.96M
株価収益率:
-0.1548
EPS:
-1.36
ネットキャッシュフロー:
$-6.37M
1週間 パフォーマンス:
-9.03%
1か月 パフォーマンス:
-79.36%
6か月 パフォーマンス:
-86.84%
1年 パフォーマンス:
-86.51%
1日の値動き範囲:
$0.2105
$0.2264
1週間の範囲:
$0.1951
$0.2284
52週間の値動き範囲:
$0.19
$2.10
Biorestorative Therapies Inc Stock (BRTX) Company Profile
名前
Biorestorative Therapies Inc
セクター
電話
(631) 760-8100
住所
40 MARCUS DRIVE, MELVILLE
Compare BRTX vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BRTX
Biorestorative Therapies Inc
|
0.2105 | 4.70M | 149.50K | -6.96M | -6.37M | -1.36 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Biorestorative Therapies Inc (BRTX) 最新ニュース
BioRestorative Therapies, Inc. to Participate in the Be+Well Beauty and Wellness Show in New York City, March 8-10, 2026 - Bitget
BioRestorative Therapies, Inc. to Participate in the - GlobeNewswire
BRTX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
BioRestorative Therapies, Inc. Issues Letter to Shareholders Highlighting Major Milestones, Regulatory Alignment, Clinical Execution and Capital Strategy - Yahoo Finance
BioRestorative Therapies Inc expected to post a loss of 36 cents a shareEarnings Preview - TradingView
Aug Breakouts: Whats the beta of BioRestorative Therapies Inc stockJuly 2025 Short Interest & Risk Managed Investment Signals - baoquankhu1.vn
Meme Stocks: Is BioRestorative Therapies Inc a speculative investmentAnalyst Downgrade & Entry Point Confirmation Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
BioRestorative Expands Global Protection for ThermoStem®, a Potentially Longer-Lasting and Safer Cell-Based Alternative to GLP-1 Drugs - The Globe and Mail
Biorestorative expands global protection for ThermoStem - marketscreener.com
BioRestorative Therapies Receives Patent Approval for Innovative Brown Adipose-Derived Stem Cell Technology Targeting Obesity and Metabolic Disorders - Quiver Quantitative
Australia clears patent for cell therapy touted as GLP-1 alternative - Stock Titan
BioRestorative (NASDAQ: BRTX) amendment shows no beneficial ownership by filer - Stock Titan
Geopolitics Watch: Whats the beta of BioRestorative Therapies Inc stockTrade Exit Report & Safe Swing Trade Setups - baoquankhu1.vn
What’s the MACD signal for BioRestorative Therapies Inc.2025 Short Interest & Daily Profit Maximizing Tips - mfd.ru
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
BioRestorative concludes Phase II BRTX-100 trial enrolment for cLDD - MSN
Degenerative Disc Disease Clinical Trial Pipeline Strengthens as 15+ Companies Advance 15+ Regenerative and Non‑Surgical Therapies Toward Market Entry, Finds DelveInsight | Spine BioPharma, Biosplice - Barchart.com
BioRestorative Therapies Raises ~$5 Million in Unit Offering; Issues Five-Year Warrants - TradingView
Will BioRestorative Therapies Inc. stock go up in YEAR2025 Trade Ideas & Verified Stock Trade Ideas - mfd.ru
Aug Levels: Is Antero Midstream Corporation stock showing strong momentum2025 Momentum Check & Target Return Focused Picks - baoquankhu1.vn
BioRestorative Therapies closes $5 million public offering By Investing.com - Investing.com Nigeria
BRTX PE Ratio & Valuation, Is BRTX Overvalued - Intellectia AI
Biorestorative Therapies (NASDAQ:BRTX) Trading 5.9% Higher – Still a Buy? - Defense World
BioRestorative Therapies, Inc. Completes Public Offering Raising Approximately $5.0 Million for Clinical and Research Initiatives - Quiver Quantitative
BRTX Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
BioRestorative Closes $5 Million Public Offering of 14.3 Million Shares - Intellectia AI
BioRestorative Therapies closes $5 million public offering - Investing.com
BioRestorative Announces Closing of $5.0 Million Public Offering - Bitget
Stem cell firm BioRestorative raises $5M for trials and R&D - Stock Titan
BioRestorative Announces Closing of $5.0 Million Public Offering - GlobeNewswire Inc.
BioRestorative prices $5M stock offering - MSN
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Form 424B4 BioRestorative Therapies - StreetInsider
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Published on: 2026-02-12 18:49:00 - mfd.ru
BioRestorative Therapies stock plunges after $5 million public offering By Investing.com - Investing.com Nigeria
BioRestorative Therapies stock plunges after $5 million public offering - Investing.com South Africa
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioRestorative Therapies (OTCMKTS:BRTXQ) Shares Down 38.9%Here's Why - MarketBeat
BioRestorative Therapies Announces $5 Million Public Offering to Fund Operations - geneonline.com
BioRestorative Announces Pricing of $5.0 Million Public Offering - The Manila Times
Stem cell developer BioRestorative seeks $5M for BRTX-100 trials - Stock Titan
BioRestorative announces pricing of $5.0 million public offering - marketscreener.com
Is BioRestorative Therapies Inc.’s growth already priced inWeekly Trade Report & Daily Risk Controlled Trade Plans - mfd.ru
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
BioRestorative Therapies, Inc. Announces Positive Outcome from Type B Meeting with FDA - marketscreener.com
BioRestorative Announces Positive Outcome From Type B Meeting With FDA - Nasdaq
Biorestorative announces positive outcome from type B meeting with FDA - marketscreener.com
BioRestorative Therapies recently updated the timeline for its core research and development pipeline - Bitget
BioRestorative Therapies Receives Positive FDA Feedback on BRTX-100 Program for Accelerated BLA Approval Pathway - Quiver Quantitative
Biorestorative Therapies Inc (BRTX) 財務データ
収益
当期純利益
現金流量
EPS
3.69%
0.68%
大文字化:
|
ボリューム (24 時間):